Publisher Correction: Programmed death ligand 1 signals in cancer cells (Nature Reviews Cancer, (2022), 22, 3, (174-189), 10.1038/s41568-021-00431-4)

Anand V.R. Kornepati, Ratna K. Vadlamudi, Tyler J. Curiel

Producción científica: Comment/debaterevisión exhaustiva

5 Citas (Scopus)

Resumen

This article was originally published with the title ‘Programmed cell death 1 ligand 1 signals in cancer cells’. This has been corrected in the HTML and PDF versions of the article to reflect the more common usage of the definition of PDL1 as ‘programmed death ligand 1’. In addition, the definitions for the acronyms PD1 (programmed death 1) and PDL1 have been added to the abstract, the introduction and display items of the article.

Idioma originalEnglish (US)
Páginas (desde-hasta)190
Número de páginas1
PublicaciónNature Reviews Cancer
Volumen22
N.º3
DOI
EstadoPublished - mar 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Huella

Profundice en los temas de investigación de 'Publisher Correction: Programmed death ligand 1 signals in cancer cells (Nature Reviews Cancer, (2022), 22, 3, (174-189), 10.1038/s41568-021-00431-4)'. En conjunto forman una huella única.

Citar esto